US Stock MarketDetailed Quotes

MRNS Marinus Pharmaceuticals

Watchlist
  • 0.371
  • +0.049+15.06%
Close Dec 27 16:00 ET
  • 0.380
  • +0.009+2.32%
Post 20:01 ET
20.50MMarket Cap-0.15P/E (TTM)

Marinus Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
22.72%-19.45M
-26.62%-30.84M
9.68%-37.46M
-4.53%-118M
-23.17%-26.99M
15.09%-25.17M
27.66%-24.36M
-49.98%-41.48M
-103.48%-112.89M
-0.75%-21.91M
Net income from continuing operations
26.53%-24.23M
-12.19%-35.83M
-11.34%-38.67M
-613.59%-141.41M
-21.73%-41.77M
-144.99%-32.97M
19.02%-31.93M
-79.38%-34.73M
79.94%-19.82M
-21.22%-34.31M
Operating gains losses
----
----
----
----
----
----
----
----
-11,345.70%-106.45M
--0
Depreciation and amortization
-5.63%134K
10.24%140K
-16.56%131K
31.82%551K
52.44%125K
-10.13%142K
36.56%127K
84.71%157K
17.75%418K
-11.83%82K
Other non cash items
-28.30%1.28M
0.55%1.83M
-2.90%1.61M
51.91%5.06M
-113.08%-207K
1,141.67%1.79M
381.00%1.82M
35.18%1.66M
212.77%3.33M
397.80%1.58M
Change In working capital
-167.31%-1.47M
-222.24%-2.66M
54.06%-5.58M
135.60%2.17M
58.39%9.94M
1,522.22%2.19M
47.93%2.18M
13.15%-12.14M
-121.23%-6.09M
63.80%6.28M
-Change in prepaid assets
72.55%1.99M
-55.78%673K
57.24%-3.83M
54.24%-2.55M
214.52%3.74M
585.12%1.15M
208.02%1.52M
-736.10%-8.96M
-553.81%-5.58M
-716.00%-3.26M
-Change in payables and accrued expense
-856.33%-4M
-938.01%-3.85M
39.09%-2.26M
-43.85%2.11M
109.73%5.67M
200.95%529K
-115.73%-371K
-374.71%-3.72M
-52.12%3.75M
-18.86%2.7M
-Change in other current liabilities
----
----
----
--0
----
----
----
----
-200.00%-22.16M
--0
-Change in other working capital
6.08%541K
-49.46%518K
-4.04%522K
-85.40%2.61M
-92.19%534K
3.87%510K
96.74%1.03M
-94.58%544K
4,058.85%17.89M
1,107.95%6.84M
Cash from discontinued investing activities
Operating cash flow
22.72%-19.45M
-26.62%-30.84M
9.68%-37.46M
-4.53%-118M
-23.17%-26.99M
15.09%-25.17M
27.66%-24.36M
-49.98%-41.48M
-103.48%-112.89M
-0.75%-21.91M
Investing cash flow
Cash flow from continuing investing activities
-109.34%-1.11M
79.24%8.96M
140.17%20.89M
-127.04%-28.61M
8,084.81%6.47M
-88.76%11.92M
1,592.54%5M
-60,359.30%-52M
7,575.05%105.77M
110.96%79K
Net PPE purchase and sale
-1,365.79%-1.11M
----
----
93.14%-110K
-143.04%-34K
93.97%-76K
----
----
44.51%-1.6M
110.96%79K
Net investment purchase and sale
--0
80.00%9M
140.17%20.89M
-126.54%-28.5M
--6.5M
-88.82%12M
--5M
---52M
7,184.60%107.38M
--0
Cash from discontinued investing activities
Investing cash flow
-109.35%-1.11M
79.10%8.96M
140.17%20.89M
-127.04%-28.61M
8,084.81%6.47M
-88.77%11.92M
1,593.73%5M
-60,359.30%-52M
7,575.05%105.77M
110.96%79K
Financing cash flow
Cash flow from continuing financing activities
-107.43%-1.93M
-7,567.51%-17.7M
247.70%257K
-78.65%26.63M
-99.30%661K
4,844.14%25.9M
1,592.86%237K
-100.56%-174K
201.96%124.74M
31,595.96%94.14M
Net issuance payments of debt
-557.24%-1.93M
-7,065.18%-17.7M
--0
--0
--0
174.91%421K
---247K
-100.59%-174K
45.33%58.51M
--29.67M
Net common stock issuance
----
----
----
-59.95%25.82M
-100.15%-97K
----
----
----
--64.48M
--64.48M
Proceeds from stock option exercised by employees
--0
--0
--257K
-55.18%804K
-32.26%21K
1,768.75%299K
3,357.14%484K
--0
49.62%1.79M
-89.56%31K
Net other financing activities
----
----
----
----
----
----
----
----
71.62%-42K
----
Cash from discontinued financing activities
Financing cash flow
-107.43%-1.93M
-7,567.51%-17.7M
247.70%257K
-78.65%26.63M
-99.30%661K
4,844.14%25.9M
1,592.86%237K
-100.56%-174K
201.96%124.74M
31,595.96%94.14M
Net cash flow
Beginning cash position
-49.39%64.68M
-29.03%104.25M
-49.88%120.57M
95.69%240.55M
-16.53%140.44M
38.41%127.79M
16.30%146.9M
95.69%240.55M
-11.25%122.93M
15.95%168.25M
Current changes in cash
-277.80%-22.49M
-107.03%-39.58M
82.57%-16.32M
-202.00%-119.98M
-127.48%-19.87M
-83.34%12.65M
43.76%-19.12M
-2,860.82%-93.65M
854.87%117.62M
426.07%72.3M
End cash Position
-69.96%42.18M
-49.39%64.68M
-29.03%104.25M
-49.88%120.57M
-49.88%120.57M
-16.53%140.44M
38.41%127.79M
16.30%146.9M
95.69%240.55M
95.69%240.55M
Free cash flow
18.57%-20.57M
-26.77%-30.88M
9.68%-37.46M
-3.02%-118.12M
-22.81%-27.03M
18.27%-25.26M
28.37%-24.36M
-49.52%-41.48M
-96.45%-114.66M
2.07%-22.01M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 22.72%-19.45M-26.62%-30.84M9.68%-37.46M-4.53%-118M-23.17%-26.99M15.09%-25.17M27.66%-24.36M-49.98%-41.48M-103.48%-112.89M-0.75%-21.91M
Net income from continuing operations 26.53%-24.23M-12.19%-35.83M-11.34%-38.67M-613.59%-141.41M-21.73%-41.77M-144.99%-32.97M19.02%-31.93M-79.38%-34.73M79.94%-19.82M-21.22%-34.31M
Operating gains losses ---------------------------------11,345.70%-106.45M--0
Depreciation and amortization -5.63%134K10.24%140K-16.56%131K31.82%551K52.44%125K-10.13%142K36.56%127K84.71%157K17.75%418K-11.83%82K
Other non cash items -28.30%1.28M0.55%1.83M-2.90%1.61M51.91%5.06M-113.08%-207K1,141.67%1.79M381.00%1.82M35.18%1.66M212.77%3.33M397.80%1.58M
Change In working capital -167.31%-1.47M-222.24%-2.66M54.06%-5.58M135.60%2.17M58.39%9.94M1,522.22%2.19M47.93%2.18M13.15%-12.14M-121.23%-6.09M63.80%6.28M
-Change in prepaid assets 72.55%1.99M-55.78%673K57.24%-3.83M54.24%-2.55M214.52%3.74M585.12%1.15M208.02%1.52M-736.10%-8.96M-553.81%-5.58M-716.00%-3.26M
-Change in payables and accrued expense -856.33%-4M-938.01%-3.85M39.09%-2.26M-43.85%2.11M109.73%5.67M200.95%529K-115.73%-371K-374.71%-3.72M-52.12%3.75M-18.86%2.7M
-Change in other current liabilities --------------0-----------------200.00%-22.16M--0
-Change in other working capital 6.08%541K-49.46%518K-4.04%522K-85.40%2.61M-92.19%534K3.87%510K96.74%1.03M-94.58%544K4,058.85%17.89M1,107.95%6.84M
Cash from discontinued investing activities
Operating cash flow 22.72%-19.45M-26.62%-30.84M9.68%-37.46M-4.53%-118M-23.17%-26.99M15.09%-25.17M27.66%-24.36M-49.98%-41.48M-103.48%-112.89M-0.75%-21.91M
Investing cash flow
Cash flow from continuing investing activities -109.34%-1.11M79.24%8.96M140.17%20.89M-127.04%-28.61M8,084.81%6.47M-88.76%11.92M1,592.54%5M-60,359.30%-52M7,575.05%105.77M110.96%79K
Net PPE purchase and sale -1,365.79%-1.11M--------93.14%-110K-143.04%-34K93.97%-76K--------44.51%-1.6M110.96%79K
Net investment purchase and sale --080.00%9M140.17%20.89M-126.54%-28.5M--6.5M-88.82%12M--5M---52M7,184.60%107.38M--0
Cash from discontinued investing activities
Investing cash flow -109.35%-1.11M79.10%8.96M140.17%20.89M-127.04%-28.61M8,084.81%6.47M-88.77%11.92M1,593.73%5M-60,359.30%-52M7,575.05%105.77M110.96%79K
Financing cash flow
Cash flow from continuing financing activities -107.43%-1.93M-7,567.51%-17.7M247.70%257K-78.65%26.63M-99.30%661K4,844.14%25.9M1,592.86%237K-100.56%-174K201.96%124.74M31,595.96%94.14M
Net issuance payments of debt -557.24%-1.93M-7,065.18%-17.7M--0--0--0174.91%421K---247K-100.59%-174K45.33%58.51M--29.67M
Net common stock issuance -------------59.95%25.82M-100.15%-97K--------------64.48M--64.48M
Proceeds from stock option exercised by employees --0--0--257K-55.18%804K-32.26%21K1,768.75%299K3,357.14%484K--049.62%1.79M-89.56%31K
Net other financing activities --------------------------------71.62%-42K----
Cash from discontinued financing activities
Financing cash flow -107.43%-1.93M-7,567.51%-17.7M247.70%257K-78.65%26.63M-99.30%661K4,844.14%25.9M1,592.86%237K-100.56%-174K201.96%124.74M31,595.96%94.14M
Net cash flow
Beginning cash position -49.39%64.68M-29.03%104.25M-49.88%120.57M95.69%240.55M-16.53%140.44M38.41%127.79M16.30%146.9M95.69%240.55M-11.25%122.93M15.95%168.25M
Current changes in cash -277.80%-22.49M-107.03%-39.58M82.57%-16.32M-202.00%-119.98M-127.48%-19.87M-83.34%12.65M43.76%-19.12M-2,860.82%-93.65M854.87%117.62M426.07%72.3M
End cash Position -69.96%42.18M-49.39%64.68M-29.03%104.25M-49.88%120.57M-49.88%120.57M-16.53%140.44M38.41%127.79M16.30%146.9M95.69%240.55M95.69%240.55M
Free cash flow 18.57%-20.57M-26.77%-30.88M9.68%-37.46M-3.02%-118.12M-22.81%-27.03M18.27%-25.26M28.37%-24.36M-49.52%-41.48M-96.45%-114.66M2.07%-22.01M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.